Journal article
A clinical trial of creatine in ALS
Abstract
BACKGROUND: Mitochondrial dysfunction occurs early in the course of ALS, and the mitochondria may be an important site for therapeutic intervention. Creatine stabilizes the mitochondrial transition pore, and is important in mitochondrial ATP production. In a transgenic mouse model of ALS, administration of creatine prolongs survival and preserves motor function and motor neurons.
METHODS: The authors conducted a randomized double-blind, placebo …
Authors
Shefner JM; Cudkowicz ME; Schoenfeld D; Conrad T; Taft J; Chilton M; Urbinelli L; Qureshi M; Zhang H; Pestronk A
Journal
Neurology, Vol. 63, No. 9, pp. 1656–1661
Publisher
Wolters Kluwer
Publication Date
November 9, 2004
DOI
10.1212/01.wnl.0000142992.81995.f0
ISSN
0028-3878